急性ST段抬高型心肌梗死溶栓治疗专家共识  

Expert consensus on thrombolytic therapy for ST-segment elevation myocardial infarction

作　　者：江苏省医学会心血管病学分会 江苏省医师协会心血管内科医师分会 江苏省医师协会心脏重症专业委员会 江苏省医学会心血管病学分会基础与药物学组 李春坚 马根山 徐标 孔祥清 黄强 Cardiology Branch of Jiangsu Medical Association;Cardiology Branch of Jiangsu Medical Doctor Association;Cardiac Critical Care Specialized Committee of Jiangsu Medical Doctor Association;Basic&Medication Panel Affiliated to Cardiology Branch of Jiangsu Medical Association;LI Chun-Jian;MA Gen-shan;XU Biao;KONG Xiang-qing

机构地区：[1]不详 [2]江南大学附属中心医院 [3]南京医科大学第一附属医院

出　　处：《中国介入心脏病学杂志》2024年第7期364-382,共19页Chinese Journal of Interventional Cardiology

基　　金：江苏省重点研发计划支持项目(BE2019754)。

摘　　要：溶栓治疗是急性ST段抬高型心肌梗死(STEMI)最重要的救治措施之一。2018年国内发布了《ST段抬高型急性心肌梗死院前溶栓治疗中国专家共识》,极大地推动和指导了STEMI的院前溶栓策略。近年来,国内外关于STEMI的溶栓治疗策略、溶栓患者的抗血小板、抗凝治疗、溶栓结合经皮冠状动脉介入治疗(PCI)策略、新冠疫情下再灌注策略等方面涌现了众多研究进展和循证证据。本共识旨在总结近年STEMI溶栓治疗领域的研究进展,并据此编定一套符合我国实际情况、临床指导性强的STEMI溶栓治疗专家共识,以期进一步优化STEMI救治流程和治疗策略,为提高STEMI患者救治成功率、改善患者长期预后做出贡献。Thrombolytic therapy plays a vital role in reperfusion strategy for ST-segment elevation myocardial infarction(STEMI)patients.Previous Chinese expert consensus focused on prehospital thrombolysis therapy in STEMI patients was published in 2018 which tremendously promoted pre-hospital thrombolysis therapy.In recent years,plenty of research progress and results of clinical trials have been released in following areas such as STEMI reperfusion strategy,anti-platelet/anti-coagulants therapy,contemporary facilitated percutaneous coronary intervention,and so on.Meanwhile,the COVID-19 pandemic makes timely reperfusion for STEMI patients even more challenging.Therefore,this consensus has been proposed aiming to summarize recent progress in STEMI thrombolysis therapy and to provide practical&evidence-based instructions conforming to national conditions.We hope this consensus will contribute to the emergency management and long-term prognosis of STEMI patients.

关 键 词：心肌梗死 溶栓 专家共识 

分 类 号：R54[医药卫生—心血管疾病]